A not-for-profit organisation with a heritage that spans 170 years, we have an ambitious international vision for the future. Around the world, we invest in educating future generations of scientists. We raise and maintain standards. We partner with industry and academia, promoting collaboration and innovation. We advise governments on policy.
And we promote the talent, information and ideas that lead to great advances in science.
In a complex and changing world, chemistry and the chemical sciences are essential. They are vital in our everyday lives and will be vital in helping the world respond to some of its biggest challenges.
We are committed to promoting, supporting and celebrating inclusion and diversity. We understand that the success of our community depends on our ability to nurture the talent of the best people regardless of who they are or their background.
We’re working to shape the future of the chemical sciences – for the benefit of science and humanity.
Medicinal chemistry is a stimulating field as it links many scientific disciplines and allows for collaboration with other scientists in researching and developing new drugs.Clean Room Pharmaceutical Factory Medicinal chemists apply their chemistry training to the process of synthesizing new pharmaceuticals. They also improve the processes by which existing pharmaceuticals are made.
Medicinal chemists are focused on drug discovery and development and are concerned with the isolation of medicinal agents found in plants, as well as the creation of new synthetic drug compounds. Most chemists work with a team of scientists from different disciplines, including biologists, toxicologists, pharmacologists, theoretical chemists, microbiologists, and biopharmacists. Together, this team uses sophisticated analytical techniques to synthesize and test new drug products and to develop the most cost-effective and environmentally friendly means of production.
The Israel Association for Medicinal Chemistry (IAMC) was founded in 1991, and following its becoming a section of the Israel Chemical Society (ICS) in 2004. It was renamed as the Medicinal Chemistry Section of the Israel Chemical Society (MCS-ICS). The MCS-ICS builds an interdisciplinary bridge between chemistry, biology,
medicine and pharmacy by organizing and fostering the interaction between medicinal chemists in academia, industry and drug dispensing institutions, in an independent association devoted to education, research and development of medicinal chemistry through meetings and workshops. The MCS-ICS is a National Adhering Organization of the European Federation of Medicinal chemistry (EFMC), participates in various activities within this organization, and sustains strong links with other member scientific societies.
The Society's aims are:
To hold symposia and annual scientific meetings.
To promote symposia on new vistas in drug research.
To conduct workshops on progress in instrumental drug analysis.
To represent the association at the EFMC and related international bodies.
The European Federation for Medicinal Chemistry (EFMC) is an independent association founded in 1970 that represents 25 scientific organisations from 23 European countries. Its objective is to advance the science of medicinal chemistry by promoting cooperation and encouraging strong links between the national adhering organisations in order to deepen contacts
and exchanges between medicinal chemists in Europe and around the World. EFMC fulfils this objective by organizing symposia and short courses, by sponsoring meetings and medicinal chemistry schools, by publishing on relevant topics and by conferring awards and prizes.
Its most important organisation is the biennial International Symposium on Medicinal Chemistry (EFMC-ISMC). These symposia, with an average attendance of 1,200 delegates, are highly international with a broad range of speakers and attendees from the pharmaceutical industry and academia.